US EditionRFK Jr.’s advisory panel may change childhood vaccine guidance
The CDC panel, reshaped under HHS Secretary Robert F. Kennedy Jr., considers delaying newborn hepatitis B vaccinations despite evidence preventing 99% of infections in children.
- On December 4 and 5, the Advisory Committee on Immunization Practices will meet, with the only formal vote concerning the hepatitis B vaccine birth dose.
- Earlier this year, Robert F. Kennedy Jr., Secretary of Health and Human Services, fired 17 ACIP members and ordered CDC webpage revisions without subject-matter review.
- Public-Health data show the hepatitis B vaccine cut acute infections by 99%, with no safety signals found in over 400 studies; it is a three-shot series starting within 24 hours.
- If the ACIP votes to change the birth dose, manufacturers and insurers could face disruptions, as altering it may destabilize the schedule and make combination vaccines unusable.
- Amid falling kindergarten vaccination coverage, experts warn of broader harm as ACIP staffing gaps and absent CDC leadership raise concerns about legitimizing fringe doubts.
251 Articles
251 Articles
Jeneen Interlandi: This is the damage Kennedy has done in less than a year
In the days before Christmas, as measles, whooping cough and influenza continued to spread and surge across the country, the Department of Health and Human Services came perilously close to scrapping the nation’s long-standing list of recommended childhood vaccines.
CDC Vaccine Panel Votes to End Universal Hep B Vaccine for Newborns
by Brenda Baletti, Ph.D., Childrens Health Defense: Advisers to the Centers for Disease Control and Prevention (CDC) this morning voted to end a decades-long recommendation that all infants born in the U.S. receive the hepatitis B vaccine (Hep B) within 12-24 hours of birth. Instead, for babies born to mothers who test negative for hepatitis B, […]
RFK Jr.'s vaccine revamp would put pregnant women and children at risk
On Friday, the Advisory Committee on Immunization Practices voted 8-3 to end its recommendation that all infants receive a vaccine for hepatitis B at birth. The vote came after a contentious discussion on Thursday, and days after Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), claimed in a memo obtained by multiple news outlets, but not made public, that the COVID-19 vaccine caused the death of 10 childre…
What Does Delaying the Hepatitis B Vaccine Mean for Babies?
The CDC's committee that helps determine vaccine guidelines has recommended delaying the hepatitis B vaccine for newborns. Here's why experts disagree.Parents/GumpanatKey TakeawaysThe hepatitis B vaccine is safe, highly effective, and best given at birth to protect babies from a lifelong liver infection.Delaying the vaccine could leave babies unprotected during a critical time and increase the risk of serious illness later in life.Experts stress…
Coverage Details
Bias Distribution
- 64% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
